• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合早期动态 F-FDG PET/CT 和常规全身 F-FDG PET/CT 在肝细胞癌中的应用。

Combined early dynamic F-FDG PET/CT and conventional whole-body F-FDG PET/CT in hepatocellular carcinoma.

机构信息

Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Nuclear Medicine, Zhongshan Hospital(Xiamen), Fudan University, Xiamen, Fujian, China.

出版信息

Abdom Radiol (NY). 2023 Oct;48(10):3127-3134. doi: 10.1007/s00261-023-03986-y. Epub 2023 Jul 13.

DOI:10.1007/s00261-023-03986-y
PMID:37439840
Abstract

OBJECTIVE

To investigate the diagnostic value of early dynamic F-FDG PET/CT(ED F-FDG PET/CT) combined with conventional whole-body F-FDG PET/CT(WB F-FDG PET/CT) in hepatocellular carcinoma (HCC), as well as the difference of early dynamic blood flow parameters and maximum standardized uptake value (SUVmax) in HCC patients with/without liver cirrhosis or microvascular invasion (MVI).

METHODS

Twenty-two consecutive patients (mean age 57.8 years) with 28 established HCC lesions (mean size 4.5 cm) underwent a blood flow study with an F-FDG dynamic scan divided into 24 sequences of 5 s each and a standard PET/CT scan. On the ED PET/CT study, an experienced PET/CT physician obtained volumes of interest (VOIs) where three blood flow estimates (time to peak [TTP], blood flow [BF], and hepatic perfusion index [HPI]) were calculated. On the WB PET/CT study, a VOI was placed on the fused scan for each HCC and maximum standardized uptake value (SUVmax) was obtained. Comparison of blood flow estimates, SUVmax, and tumor/background ratio (TNR) was performed among HCCs with and without angioinvasion, as well as HCCs in cirrhotic and non-cirrhotic liver.

RESULTS

Compared with WB F-FDG PET/CT alone, ED combined with WB F-FDG PET/CT can significantly increase the detection rate of moderately differentiated and poorly differentiated HCCs (both P < 0.05). HPI was higher in HCCs in patients with liver cirrhosis than those without liver cirrhosis (P = 0.044). There was no significant difference in TTP, BF, SUVmax, or TNR between HCCs in patients with liver cirrhosis and those without liver cirrhosis. There was no significant difference in blood flow estimates or SUVmax in background liver parenchyma between patients with and those without cirrhosis. TTP was shorter in HCCs with MVI than without MVI (P = 0.046). There was no significant difference in BF, HPI, SUVmax, or TNR between HCCs with MVI and without MVI. There was no significant difference in blood flow estimates or SUVmax in background liver parenchyma between patients with and those without MVI.

CONCLUSION

ED combined with WB F-FDG PET/CT can significantly increase the detection rate of moderately differentiated and poorly differentiated HCCs. HPI was significantly higher in HCCs in patients with liver cirrhosis than those without liver cirrhosis. TTP was significantly shorter in HCCs with MVI than without MVI.

摘要

目的

探讨早期动态 F-FDG PET/CT(ED F-FDG PET/CT)联合常规全身 F-FDG PET/CT(WB F-FDG PET/CT)对肝细胞癌(HCC)的诊断价值,以及肝硬化或微血管侵犯(MVI)患者 HCC 之间早期血流动力学参数和最大标准化摄取值(SUVmax)的差异。

方法

22 例连续患者(平均年龄 57.8 岁)共 28 个已确诊 HCC 病变(平均大小 4.5cm)接受 F-FDG 动态扫描血流研究,共 24 个 5s 序列,并进行标准 PET/CT 扫描。在 ED PET/CT 研究中,一位经验丰富的 PET/CT 医师获得了三个血流估计值(达峰时间[TTP]、血流[BF]和肝灌注指数[HPI])的感兴趣区(VOI)。在 WB PET/CT 研究中,在融合扫描上为每个 HCC 放置了一个 VOI,并获得了最大标准化摄取值(SUVmax)。比较了有和无血管侵犯的 HCC 之间、肝硬化和非肝硬化肝之间的血流估计值、SUVmax 和肿瘤/背景比(TNR)。

结果

与单独的 WB F-FDG PET/CT 相比,ED 联合 WB F-FDG PET/CT 可显著提高中、低分化 HCC 的检出率(均 P<0.05)。肝硬化患者 HCC 的 HPI 高于非肝硬化患者(P=0.044)。肝硬化患者与非肝硬化患者 HCC 的 TTP、BF、SUVmax 或 TNR 无显著差异。肝硬化患者与非肝硬化患者背景肝实质的血流估计值或 SUVmax 无显著差异。MVI 患者 HCC 的 TTP 短于无 MVI 患者(P=0.046)。有 MVI 和无 MVI 的 HCC 之间的 BF、HPI、SUVmax 或 TNR 无显著差异。有 MVI 和无 MVI 的患者背景肝实质的血流估计值或 SUVmax 无显著差异。

结论

ED 联合 WB F-FDG PET/CT 可显著提高中、低分化 HCC 的检出率。肝硬化患者 HCC 的 HPI 明显高于非肝硬化患者。有 MVI 的 HCC 的 TTP 明显短于无 MVI 的 HCC。

相似文献

1
Combined early dynamic F-FDG PET/CT and conventional whole-body F-FDG PET/CT in hepatocellular carcinoma.联合早期动态 F-FDG PET/CT 和常规全身 F-FDG PET/CT 在肝细胞癌中的应用。
Abdom Radiol (NY). 2023 Oct;48(10):3127-3134. doi: 10.1007/s00261-023-03986-y. Epub 2023 Jul 13.
2
FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.肝细胞癌 FDG PET/CT 早期血流动力学及晚期标准化摄取值测定。
Radiology. 2011 Aug;260(2):503-10. doi: 10.1148/radiol.11102350. Epub 2011 May 9.
3
Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.早期动态 18F-FDG PET 检测肝细胞肝癌病灶的高灌注。
J Nucl Med. 2013 Jun;54(6):848-54. doi: 10.2967/jnumed.112.113936. Epub 2013 Mar 25.
4
The value of preoperative 18F-FDG PET metabolic and volumetric parameters in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinoma.术前 18F-FDG PET 代谢和容积参数在预测肝细胞癌微血管侵犯和术后复发中的价值。
Nucl Med Commun. 2022 Jan 1;43(1):100-107. doi: 10.1097/MNM.0000000000001478.
5
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.18F-FDG PET/CT 对肝癌患者肝移植前血管侵犯的预测价值。
Clin Nucl Med. 2017 Apr;42(4):e183-e187. doi: 10.1097/RLU.0000000000001545.
6
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using F-FDG PET/CT: a multicenter retrospective cohort study.使用 F-FDG PET/CT 对肝细胞癌微血管侵犯的术前预测:一项多中心回顾性队列研究。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):720-726. doi: 10.1007/s00259-017-3880-4. Epub 2017 Nov 22.
7
Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.联合早期动态(18)F-FDG PET/CT和传统全身(18)F-FDG PET/CT可为检测肝细胞癌提供一站式成像。
Clin Res Hepatol Gastroenterol. 2015 Jun;39(3):324-30. doi: 10.1016/j.clinre.2014.10.010. Epub 2014 Nov 11.
8
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.肝胆磁共振对比剂摄取作为预测病理侵袭性特征和降低可切除肝细胞癌无复发生存率的生物标志物:与双示踪剂 18F-FDG 和 18F-FCH PET/CT 的比较。
Eur Radiol. 2020 Oct;30(10):5348-5357. doi: 10.1007/s00330-020-06923-5. Epub 2020 May 13.
9
Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma.术前氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描预测小肝癌微血管侵犯情况
J Comput Assist Tomogr. 2016 Jul-Aug;40(4):524-30. doi: 10.1097/RCT.0000000000000405.
10
Feasibility of perfusion and early-uptake F-FDG PET/CT in primary hepatocellular carcinoma: a dual-input dual-compartment uptake model.原发性肝细胞癌灌注和早期摄取 F-FDG PET/CT 的可行性:双输入双室摄取模型。
Jpn J Radiol. 2021 Nov;39(11):1086-1096. doi: 10.1007/s11604-021-01140-6. Epub 2021 Jun 2.

引用本文的文献

1
Dynamic FDG PET/CT imaging: quantitative assessment, advantages and application in the diagnosis of malignant solid tumors.动态氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描成像:定量评估、优势及在恶性实体瘤诊断中的应用
Front Oncol. 2025 Apr 14;15:1539911. doi: 10.3389/fonc.2025.1539911. eCollection 2025.

本文引用的文献

1
Total-Body Dynamic Reconstruction and Parametric Imaging on the uEXPLORER.uEXPLORER 全身动态重建与参数成像。
J Nucl Med. 2020 Feb;61(2):285-291. doi: 10.2967/jnumed.119.230565. Epub 2019 Jul 13.
2
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
3
F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches.氟脱氧葡萄糖正电子发射断层扫描在肝癌诊断中的应用:对根治性和非根治性治疗策略的启示
Therap Adv Gastroenterol. 2019 Mar 19;12:1756284819836205. doi: 10.1177/1756284819836205. eCollection 2019.
4
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.肝细胞癌微血管侵犯的预后和治疗意义。
Ann Surg Oncol. 2019 May;26(5):1474-1493. doi: 10.1245/s10434-019-07227-9. Epub 2019 Feb 20.
5
Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Preoperative Gd-EOB-DTPA-Dynamic Enhanced MRI and Histopathological Correlation.肝细胞癌微血管侵犯的预测:术前钆塞酸二钠动态增强 MRI 与组织病理学相关性。
Contrast Media Mol Imaging. 2018 Jan 23;2018:9674565. doi: 10.1155/2018/9674565. eCollection 2018.
6
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using F-FDG PET/CT: a multicenter retrospective cohort study.使用 F-FDG PET/CT 对肝细胞癌微血管侵犯的术前预测:一项多中心回顾性队列研究。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):720-726. doi: 10.1007/s00259-017-3880-4. Epub 2017 Nov 22.
7
Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.手术治疗肝细胞癌后标本中微血管侵犯的意义。
J Gastroenterol Hepatol. 2018 Feb;33(2):347-354. doi: 10.1111/jgh.13843.
8
Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.原发性肝癌病理诊断实践指南:2015年更新版
World J Gastroenterol. 2016 Nov 14;22(42):9279-9287. doi: 10.3748/wjg.v22.i42.9279.
9
Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT.慢性肝脏疾病与 [(18)F]氟胆碱 PET/CT 检测肝细胞癌。
Diagnostics (Basel). 2015;5(2):189-99. doi: 10.3390/diagnostics5020189.
10
Combined early dynamic (18)F-FDG PET/CT and conventional whole-body (18)F-FDG PET/CT provide one-stop imaging for detecting hepatocellular carcinoma.联合早期动态(18)F-FDG PET/CT和传统全身(18)F-FDG PET/CT可为检测肝细胞癌提供一站式成像。
Clin Res Hepatol Gastroenterol. 2015 Jun;39(3):324-30. doi: 10.1016/j.clinre.2014.10.010. Epub 2014 Nov 11.